Search

Your search keyword '"Mazouni, C."' showing total 106 results

Search Constraints

Start Over You searched for: Author "Mazouni, C." Remove constraint Author: "Mazouni, C." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
106 results on '"Mazouni, C."'

Search Results

1. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study

3. 140P Benefit of adjuvant chemotherapy in luminal A-like early breast cancer in women aged 40 years or younger: Results of a national multi-institutional study

5. 50P Early breast cancer in women aged 35 years or younger: A French population-based case control-matched analysis

11. Adjuvant chemotherapy in elderly breast cancer patients: Pattern of use and impact on overall survival

12. Abstract P2-08-08: Isolated ipsilateral local recurrence of breast cancer: Predictive factors and prognostic impact

13. Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas

14. Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast

15. Impact of hormone receptor status in HER2+ early breast cancer: A paradigm shift in the trastuzumab era

16. Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial

18. Abstract PD7-06: MAAT: Menses after adjuvant treatment. Prediction of menses recovery after chemotherapy for early breast cancer (BC) by using a nomogram model in UNICANCER PACS04 and PACS05 trials

19. Abstract P2-11-17: Is post mastectomy radiotherapy contributive in pN0-1mi breast cancers patients? Results of a French multi-centric cohort

21. Abstract P3-10-03: Receipt of breast cancer risk assessment and personalized prevention information among women diagnosed with a benign breast lesion (BBL) in a one stop breast unit: A prospective assessment

27. Abstract P4-14-12: Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after mastectomy with axillary lymph node dissection for breast cancer: results of a phase 2 randomized study.

32. OT2-07-01: Pasireotide Long Acting Release (LAR) in Breast Cancer Patients To Prevent Lymphocele after Mastectomy and Axillary Node Dissection: A Randomized, Multicenter, Phase II Study.

39. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer.

40. Decision making from multidisciplinary team meetings to bedside: factors predicting for physicians' and breast cancer patients' acceptance of clinical trials proposed by MTMs.

41. A nomogram based on clinical, imaging and histological data to predict the risk of upgrades to malignancy at surgery in biopsy-diagnosed premalignant lesions of the breast.

43. Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after mastectomy with axillary lymph node dissection for breast cancer: results of a phase 2 randomized study.

44. Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.

45. Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis.

46. The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.

47. Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes.

48. Adipose Tissue Properties in Tumor-Bearing Breasts.

49. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model.

50. Sentinel lymph node biopsy validation for large tumors.

Catalog

Books, media, physical & digital resources